Identification of neocortical binding partners of CAV1 could provide valuable insight into mechanisms of CPN subtype development/refinement through complex networks of discrete protein-protein interactions, with potential implications for subtypes of autism spectrum disorders (ASD) and/or schizophrenia. This evidence concerns the gene CAV1 and schizophrenia.